VEGFA and lymphoma: The increased level of PDGF-CC produced by CAFs resulted in rendering tumor cells resistant to anti-VEGF therapy by stimulation of neoangiogenesis, when lymphoma cells otherwise sensitive to anti-VEGF therapy were co-implanted with these fibroblasts into recipient mice [93].